Tango Therapeutics
Discovering novel cancer medicines
- B2B
About Tango Therapeutics
Biotechnology company developing novel cancer therapies targeting vulnerabilities with advanced DNA sequencing and CRISPR technology, focusing on genetic subtypes for precision medicine
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- boston, massachusetts, United States
- Founded
- 2017
- Revenue
- $62.4MFY2025, publicly reported
- Website
- tangotx.com
Tango Therapeutics at a glance
Tango Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in boston, massachusetts, United States.
Tango Therapeutics was founded in 2017.
Tango Therapeutics has 51–250 employees.
Tango Therapeutics's revenue is $62.4M (FY2025, publicly reported).
Selling to companies like Tango Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies